ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Business Roundup

August 21, 2006 | APPEARED IN VOLUME 84, ISSUE 34

Celsis International has acquired In Vitro Technologies for $30 million in cash. Celsis will pay up to $5 million more if In Vitro exceeds financial targets for 2006. Celsis says the acquisition will broaden its line of in vitro diagnostic products.

Mitsui Chemicals has agreed to set up a technical center in Singapore in collaboration with the Singapore government's Institute of Chemical & Engineering Sciences. The center will conduct research on catalysis and asymmetric synthesis.

BASF has signed a oneyear R&D agreement with Singapore-based NanoMaterials Technology. BASF says its new Competence Center for Nanostructured Surfaces in Singapore will test NMT's technology for producing zinc oxide nanosuspensions.

Koch Nitrogen is acquiring Simplot Canada, a nitrogen fertilizer subsidiary of agribusiness company J. R. Simplot, for an undisclosed sum. Simplot Canada operates a fertilizer complex in Brandon, Manitoba.

Akzo Nobel will seek shareholder approval on Sept. 7 for the previously proposed separation of its pharmaceuticals business. It plans to list 20-30% of the business on the stock market early next year and then sell the rest after two to three years.

Bayer MaterialScience has named Patrick W. Thomas as the chairman of its board of management. Thomas worked for ICI and Huntsman Corp. for more than 25 years and was most recently a management consultant.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment